Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SOLV 1Q24 Results by Business Segment
*Includes components for other companies’ medical devices.
%Corp YoY Growth
Segment Sales (const currency)
Medical/surgical* 56% flat
Dental 17% flat
Health-info systems 16% flat
Purification/filtration 12% +7%
SOLV’s “AI play”—>heath-information systems segment:
https://finance.yahoo.com/news/solventum-introduces-denials-prevention-solution-130000721.html
Heath-information systems comprised 16% of SOLV’s overall (pro forma) sales in 1Q24 (#msg-174387294), but SOLV expects this figure to steadily increase due to the application of AI.
Thank for the excellent post. Very useful.
SOLV reports pro forma 1Q24 results—reiterates 2024 guidance:
https://finance.yahoo.com/news/solventum-reports-first-quarter-2024-105000516.html
SOLV was spun out of 3M on 4/1/24, so the 1Q24 financial results are pro forma based on what SOLV would have reported if it had it been an independent company.
SOLV re-iterated 2024 guidance given on 3/19/24—see #msg-174067513. (2024 guidance includes the pro forma financials for 1Q24 and actual SOLV results for the remainder of the year.)
The only consequential update is that SOLV is not initiating a dividend, so that free cash flow can be directed toward paying down debt. This decision is not surprising in light of the large debt load SOLV took on as part of the spinoff from 3M.
p.s. No 1Q24 CC due to the Investor Day webcast just a few weeks ago.
All of a sudden, I own shares of SOLV! I guess I should have been paying more attention to 3M.
I've had 3M for years and years, just collecting the dividend and probably not paying enough attention to it!
SOLV begins trading on NYSE following completion of spinoff from 3M:
https://finance.yahoo.com/news/solventum-begins-trading-york-stock-103000676.html
SOLV issues 2024 guidance:
https://finance.yahoo.com/news/solventum-hosts-inaugural-investor-day-103000871.html
• Organic revenue growth of -2% to 0%
• Adjusted earnings per share (EPS) of $6.10 to $6.40
• Free cash flow of $700M to $800M
Details of 3M’s SOLV spinoff finalized:
https://finance.yahoo.com/news/3m-board-directors-approves-spin-165500127.html
3M shareholders of record on 3/18/24 will receive 1 share of SOLV for every 4 shares of 3M. The SOLV shares will be distributed before the market open on 4/1/24.
This is a tax-exempt distribution for US residents.
SOLV sells $6.9B of debt in six tranches:
• $1B of 3yr notes @5.45%
• $1.5B of 5yr notes @5.40%
• $1B of 7yr notes @5.45%
• $1.65B of 10yr notes @5.60%
• $1.25B of 30yr notes @5.90%
• $0.5B of 40yr notes @6.00%
The total debt issuance was supposed to $8.4B (according to 3M's recent webcast), but I don't know where the other $1.5B is coming from.
All but $600M of the proceeds will be paid to 3M as consideration for the spin-off of 3M’s healthcare business to SOLV.
SOLV is holding an Investor Day webcast 3/19/24 at 9am ET.
These are the five focal areas for 3M’s healthcare business that will become part of Solventum; they comprise about 25% of 3M’s current company-wide sales:
https://engage.3m.com/purification
https://www.3m.com/3M/en_US/health-information-systems-us/
https://www.3m.com/3M/en_US/medical-us/ (surgical supplies and wound care)
https://www.3m.com/3M/en_US/medical-device-components-us/ (components for other companies’ medical devices)
https://www.3m.com/3M/en_US/oral-care-us/ (dentistry and othodontics)
Further details of 3M/SOLV capitalization:
SOLV will sell $8.4B of new debt, keeping $600M of the proceeds and paying $7.7B as a one-time (tax-free) dividend to 3M. (~$100M of the debt proceeds will go to underwriting fees.)
After the debt issuance and one-time payment to 3M, SOLV will have a debt/EBITDA ratio of ~3.5.
3M sets 4/1/24 date for Solventum spin-off:
https://d1io3yog0oux5.cloudfront.net/_28c5051c41e86ce7771a2dfe11a5ee94/3m/news/2024-02-21_3M_Announces_Filing_of_Form_10_Registration_1826.pdf
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
14
|
Created
|
02/21/24
|
Type
|
Free
|
Moderators DewDiligence |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |